Redinex Life Sciences Private Limited, a active private limited company, was established on 05 October 2018 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999DL2018PTC340121. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Romi Bansal (Director), Meva Singh (Additional Director). Past directors included Karan Deep Garg, Shaminder Kumar, Vishal Garg. It holds ₹3.26 Cr open charges and ₹9.90 M settled loans. Its latest AGM occurred on 28 September 2025, with the balance sheet filed on 31 March 2025. It is based at Second Floor, Cw-234, Pvt Shop No 2, Sanjay Gandhi Transport Nagar, Delhi, Delhi, 110042.
U74999DL2018PTC340121
340121
05 October 2018
₹2.50 M
₹1.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Redinex Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Romi Bansal | Director | 05 Oct 2018 | Current |
| Meva Singh | Additional Director | 23 Jul 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Mar 2025 | Past |
| Pramod Abcsdd | Director | 16 May 2022 | Past |
| Pramod Abcsdd | Director | 06 Aug 2022 | Past |
| Pramod Abcsdd | Additional Director | 23 Jul 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Redinex Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.62% increase. The company also saw a slight improvement in profitability, with a 6.18% increase in profit. The company's net worth Soared by an impressive increase of 87.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Redinex Life Sciences had a public holding of 0.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹32,600,000.00
₹9,900,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Dec 2023 | Others | ₹1.60 M | Open |
| 08 Dec 2022 | Others | ₹3.10 Cr | Open |
| 30 Aug 2019 | Others | ₹6.40 M | Satisfied |
| 30 Aug 2019 | Others | ₹3.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Redinex Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Redinex Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Redinex Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Redinex Life Sciences Private Limited last Annual general meeting of members was held on 28 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Meva Singh was appointed as a Additional Director was appointed as a Additional Director on 23 Jul 2025 & has been associated with this company since 5 months 4 days . was completed.
Redinex Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
A charge with Others of Rs. 31.00 M registered on 08 Dec 2022 with Charge ID 100660190 was modified on 20 Aug 2024. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 1.60 M with Charge ID 100856170 was registered on 13 Dec 2023. was documented.
The activity A charge registered on 30 Aug 2019 via Charge ID 100289421 with Others was fully satisfied on 06 Apr 2023. was completed.
The CIN of Redinex Life Sciences Private Limited is U74999DL2018PTC340121.
Redinex Life Sciences Private Limited is headquartered at Second Floor, Cw-234, Pvt Shop No 2, Sanjay Gandhi Transport Nagar, Delhi, Delhi, 110042.
Redinex Life Sciences Private Limited was incorporated on 05 October 2018.
The current directors of Redinex Life Sciences Private Limited are
The primary industry of Redinex Life Sciences Private Limited is Manufacturing.
Redinex Life Sciences Private Limited is unlisted.
The authorized capital of Redinex Life Sciences Private Limited is ₹2.50 M, and the paid-up capital is ₹1.00 M.
The compliance status of Redinex Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX